Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book

Innovative Journal of Pediatrics

The Scientific Journal of Growth & Development Research Center

Home
Accepted ManuscriptsCurrent IssueAll IssuesIn Press ArticlesSearch
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormAnnouncementSupportContact Us
APC
Authors GuideSubmit Manuscript

Crossref

1. Curosurf Versus BLES in the Treatment of Preterm Neonates with Respiratory Distress Syndrome: A Randomized Clinical Trial

- Vahidreza Ostadmohammadi

- Mohammad Javad Namazi

- Mahsa Rezasoltani

- Mohammadreza Sharif

- Farzaneh Sharifi

- Ahmad Safari

- Alireza Sharif

2. The Care of Preterm and Term Newborns with Respiratory Conditions: A Systematic Synthesis of Evidence from Low- and Middle-Income Countries

- Georgia Dominguez

- Oviya Muralidharan

- Rachel Lee Him

- Leila Harrison

- Tyler Vaivada

- Zulfiqar A. Bhutta

3. The Impact of Nonequilibrium Conditions in Lung Surfactant: Structure and Composition Gradients in Multilamellar Films

- Jenny Marie Andersson

- Kevin Roger

- Marcus Larsson

- Emma Sparr

4. Comparison of the Effectiveness of Beraksurf and Curosurf Exogenous Surfactants in the Treatment of Respiratory Distress Syndrome in Preterm Neonates: A Double-blind Randomized Study in the West of Iran

- Fatemeh Eghbalian

- Behnaz Basiri

- Behnaz Hatami

- Narges Mohammadi Parsa

- Ensiyeh Jenabi

5. A systematic scoping review of the use of surfactant replacement therapy for respiratory distress syndrome in preterm neonates in low- and middle-income countries

- Caris A. Price

- Lloyd Tooke

- Heather J. Zar

- Brenda M. Morrow

6. Comparison of Efficacy of Beractant (SURVANTA®) and Poractant Alfa (CUROSURF®) in Preterm Infants With Respiratory Distress Syndrome in Tawam Hospital, Al Ain, UAE: A Retrospective Study

- Fahad Butt

- Huda Mohamad

- Nour Abusallout

- Alaa Zaineh

- Feryal El khatib

- Sarah Abdulrahman

- Sara Hamwi

- Mohamed Rahmani

- Mustafa Alabdullatif

7. In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome

- Francesca Ricci

- Fabrizio Salomone

- Elke Kuypers

- Daan Ophelders

- Maria Nikiforou

- Monique Willems

- Tobias Krieger

- Xabier Murgia

- Matthias Hütten

- Boris W. Kramer

- Federico Bianco

8. Evaluation of the Potential Association Between Cannabinoid Receptor 2 Gene Q63R Polymorphism (Rs35761398) and Risk of RDS Development in Preterm Neonates

- Sima Binaafar

- Majid Kalani

- Fatemeh Nayeri

- Shiva Irani

- Vahid Salimi

- Mamak Shariat

- Nikoo Niknafs

- Hosein Dalili

- Elaheh Amini

- Tahereh Esmaeilnia Shirvani

- Amir-Kamal Hardani

- Roya Taheritafti

- Nasrin Ghasemi-Fakhr

- Mohsen Ghadami

- Javad Tavakkoly-Bazzaz

- Ali Rashidi-Nezhad

9. Expression of Concern for Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial [Iran J Pediatr. 2016;26(5): e5743]

- Vahid Ziaee